Nature Chemical Biology is a monthly, peer-reviewed, scientific journal, which is published by Nature Publishing Group. It was first published in June 2005 (volume 1, issue 1). Terry L. Sheppard is a full-time professional editor with the title, "Chief Editor", and employed by Nature Chemical Biology. The impact factor for Nature Chemical Biology in 2010 is 15.808, according to the Journal Citation Reports. The publishing focus of Nature Chemical Biology is a forum for original research and commentary in Chemical-biology. Published topics encompass concepts and research methods in chemistry, biology, and related disciplines with the end result of controlling biological systems at the molecular level. Authors (contributors) are chemical biologists, also chemists involved in interdisciplinary research between chemistry and biology, along with biologists who produce research results in understanding and controlling biological processes at the molecular level. Interdisciplinary research in chemistry and biology is emphasized. The journal s main focus in this area is fundamental research which illuminates available chemical and biological tools, as well as mechanisms underpinning
Rice University synthetic biologists have developed a new way to study a sensory system that salmonella, E. coli and other pathogens use to sicken millions of people each year.
Dec 12, 2022
0
31
Aging involves complicated plot twists and a large cast of characters: inflammation, stress, metabolism changes, and many others. Now, a team of Salk Institute and UC San Diego scientists reveal another factor implicated ...
Oct 31, 2022
0
94
Rates of anxiety and depression have been increasing around the world for decades, a trend that has been sharply exacerbated by the COVID-19 pandemic. New research led by the Boyce Thompson Institute's Frank Schroeder could ...
Oct 13, 2022
0
83
In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.
Jul 26, 2022
0
169
A drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease, according to a Nature Chemical Biology study from researchers ...
Jan 19, 2022
0
291
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient's own immune cells to fight cancer. These treatments have energized cancer care, especially for people with certain ...
Dec 30, 2021
0
172
A new study published in Nature reports on a new antibiotic that binds to the ribosome of bacterial cells and stops drug-resistant pathogens from making mice sick.
Oct 28, 2021
0
115
Findings from a University of Kentucky College of Medicine study could lead to a new way to combat the bacteria responsible for tooth decay.
Aug 9, 2021
0
612
A discovery involving multiple teams from across Scripps Research has revealed a powerful new approach for treating diabetic foot ulcers, which affect millions of people in the US and often lead to serious complications.
Mar 23, 2021
0
75
A team of researchers co-led by Michael Frohman, MD, Ph.D., of Stony Brook University, has identified an important cause of congenital heart disease. They discovered that certain loss of functions in the PLD1 (Phospholipase ...
Mar 2, 2021
0
47
